Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract
PaperCitations, authors & open-access status
Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 382 citations, 2007 year and closed oa status.
382
Citations
2007
Year
closed
OA Status